SACRAMENTO, Calif. — California is capping the price of insulin to help the millions of Californians diagnosed with diabetes. Governor Gavin Newsom signed a new law that will limit copays for a 30-day ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...

In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...

A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ...

People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...

The maker of a new category of small, wearable insulin patch pumps—designed to comfortably provide therapy to people with diabetes while they sleep—has raised $23.6 million in early venture capital to ...

The U.S. Food & Drug Administration has issued an urgent medical device correction. Specifically, an error on the t:slim X2 insulin pump has been stopping insulin ...

A new treatment for type 1 diabetes is moving closer to reality. In late 2024, a 46-year-old Swedish man received 17 injections of a unique pancreatic cell cocktail. The cells, donated from a healthy ...

Insulin is rising in cost despite its necessity for survival for people with diabetes. Patent evergreening by insulin manufacturers hinders competition and keeps prices high. Congress should pass ...

A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered cell transplants, without needing drugs to prevent rejection. The case, ...

Washington, D.C., Metropolitan Police Department Chief Pamela Smith is facing backlash and mockery on social media after she appeared to not understand a question from the media about the department's ...

O'Reilly Automotive Inc. is suing major pharmacy benefit managers (PBMs) and insulin manufacturers, alleging collusion to inflate insulin prices. The lawsuit accuses CVS Caremark, Express Scripts, ...